Astellas to Establish a New Manufacturing Facility for API of Prograf in Toyama Technology Center
Shots:
- Astellas will construct the Third Fermentation Building as the manufacturing facility for API of Prograf (tacrolimus hydrate) in the Toyama Technology Center of Astellas Pharma
- The establishment of the new facility will enhance Astellas’ production capacity- enabling the stable supply of Prograf in future
- The total construction cost of the facility will be ~$90M with three above-ground floors having a total floor area of ~ 7-220 m2. The construction is expected to be initiated in Apr’20 with its anticipated completion in Aug’21
Click here to read full press release/ article
Ref: Astellas | Image: Astellas
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com